• No results found

18 results with keyword: 'glut related micrornas glycolysis clear cell renal carcinoma'

GLUT-1 related microRNAs and glycolysis in clear cell renal cell carcinoma

Recently, this reprogramming has been connected with microRNAs (miRNAs) since they are able to regulate gene expression at a post-transcriptional level in several

Protected

N/A

117
0
0
2021
Oncogenic microRNAs characterization in clear cell renal cell carcinoma

Using ccRCC and matched normal kidney samples, it was also evidenced that the increased levels of miR-185 and miR-21 in tumors correlate with the loss of function of specific

Protected

N/A

7
0
0
2021
Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1

• Clear cell renal cell carcinoma 75-80% • Multilocular clear cell renal cell carcinoma (cystic) 1% (?) • Papillary renal cell carcinoma (Type I and II) 10%

Protected

N/A

19
0
0
2021
Histopathology and prognosis in renal cancer

Clear cell carcinoma 70-75% Papillary renal cell carcinoma 10-15% Chromophobe renal cell carcinoma 3-5% Oncocytoma 3-5% Others 1%. Clear cell

Protected

N/A

5
0
0
2021
Summary. Background. Signature: Pol J Radiol, 2017; 82: DOI: /PJR

ccRCC – clear cell renal cell carcinoma; chRCC – chromophobe renal cell carcinoma; pRCC – papillary renal cell carcinoma; sRCC – sarcomatoid renal cell carcinoma; cttRCC

Protected

N/A

8
0
0
2021
Identification of clear cell renal cell carcinoma and oncocytoma using a three gene promoter methylation panel

RCT: renal cell tumour; RCC: renal cell carcinoma; ccRCC: clear cell renal cell carcinoma; pRCC: papillary renal cell carcinoma; chRCC: chromophobe renal cell carcinoma; RO:

Protected

N/A

9
0
0
2020
MicroRNAs in clear cell renal cell carcinoma: biological functions and applications

Similarly, miR- 1826 that is significantly downregulated in renal cancer tissues acts as tumor suppressor agent promoting apoptosis and cell cycle arrest by knockdown of CTNNB1

Protected

N/A

13
0
0
2021
Nodular Vascular Transformation of the Lymph Node Sinuses Mimicking Sarcomatoid Change in Renal Cell Carcinoma: A Potential Diagnostic Pitfall

vascular transformation of lymph node sinuses, sarcomatoid renal cell carcinoma, high-grade renal cell carcinoma, clear cell renal cell carcinoma, metastatic renal cell

Protected

N/A

6
0
0
2021
SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis

Here, by integrated gene expression and metabolomic analyses of 36 matched pairs of tumor and adjacent normal tissues, we showed that expression of Sentrin/SUMO-specific protease

Protected

N/A

15
0
0
2020
Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy

RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; mRCC : metastatic renal cell carcinoma; pRCC : papillary renal cell carcinoma; MET: proto-oncogene MET;

Protected

N/A

15
0
0
2020
Neuroendocrin tumors, GIST, cancer of unknown primary. Renal neoplasms.

Acquired cystic disease-associated renal cell carcinoma Clear-cell papillary (tubulopapillary) renal cell carcinoma Hereditary leiomyomatosis-associated renal cell carcinoma Renal

Protected

N/A

44
0
0
2021
Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression

RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; PRCC : papil- lary renal cell carcinoma; ChRCC : chromophobe renal cell carcinoma; TCGA : The Cancer Genome

Protected

N/A

6
0
0
2020
Comprehensive characterization of immune  and inflammation associated biomarkers based on multi omics integration in kidney renal clear cell carcinoma

KIRC: kidney renal clear cell carcinoma; RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; TCGA : The Cancer Genome Atlas; GO: gene ontology; KEGG:

Protected

N/A

13
0
0
2020
MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma

To address this question, the present study had three aims: (1) to extract and purify tumor-associated epithelial cell adhesion mole- cule (EpCAM)-positive exosomes; (2) to

Protected

N/A

8
0
0
2021
Case Report Synchronous renal neoplasms: clear cell renal cell carcinoma, papillary renal cell carcinoma, and multilocular cystic renal cell neoplasm of low malignant potential in the same kidney

Synchronous renal neoplasms: clear cell renal cell carcinoma, papillary renal cell carcinoma, and multilocular cystic renal cell neoplasm of low malignant potential in the

Protected

N/A

6
0
0
2020
Alpin D. Malkan, MD Senior Fellow, St. Jude Children s Research Hospital Le Bonheur Children s Hospital Grand Rounds January 14, 2015

Renal lesions in children Malignant Wilms tumor Clear Cell Sarcoma Renal Cell Carcinoma Clear cell Medullary carcinoma Multicystic Chromophil Chromophobe Collecting duct

Protected

N/A

108
0
0
2021
Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis

ChRCC : chromophobe renal cell carcinoma; nccRCC : non-clear cell renal cell carcinoma; RCC : renal cell carcinoma; TCGA : The Cancer Genome Atlas; WGCNA: weighted gene

Protected

N/A

12
0
0
2020
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma

RCC: renal cell carcinoma; ccRCC: clear cell renal cell carcinoma; mRCC: meta- static renal cell carcinoma; VHL: von Hippel–Lindau; HIFs: hypoxia-inducible factors; EGF:

Protected

N/A

9
0
0
2020

Upload more documents and download any material studies right away!